B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome

REACTOME PATHWAY
Reactome: R-HSA-99449974 genes1 compounds

The Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome pathway (Reactome ID: R-HSA-9944997) involves 4 genes and is affected by 1 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ASH2LDPY30RBBP5WDR5

Compounds Affecting Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome

#CompoundTargets HitStudies
1s adenosylhomocysteine300

About the Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome Pathway

The Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome pathway is catalogued in Reactome (ID: R-HSA-9944997) and involves 4 genes. In the BiohacksAI corpus, 1 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ASH2L, DPY30, RBBP5, WDR5.